The stock plummeted approximately 22% to reach 46 cents per share. In light of these circumstances, Eight Capital analyst Ty Collin revised his price target for Canopy Growth, setting it at $0 instead of C$1.75 ($1.32) per share. Collin also reiterated a sell rating for the company, stating that it is no longer appropriate to consider Canopy Growth as a viable business.
Cannabis can make ideas feel unusually profound by loosening self-criticism, everyday logic and the mental…
Teen cannabis use has fallen across three national surveys while legal markets have opened. At…
A new collaboration brings together iconic functional glass, carefully selected cannabis genetics and a mission…
This interview by Micah Johnson originally appeared in High Times Local, produced under license by…
Congress's watchdog confirmed the DEA has no complete written procedures for drug scheduling. Learn why…
This column originally appeared in Cultivated, a cannabis industry newsletter. Subscribe here. You know the…